Markers including matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 are prevalent in individuals with obstructive sleep apnea (OSA), hypertension, myocardial infarction, and heart failure. This evidence concerns the gene TIMP1 and myocardial infarction.